Cortical 5-HT1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS.
Turner
M R
MR
Department of Neurology, John Radcliffe Hospital, Headley Way, Oxford, UK. turnermr@doctors.org.uk
Rabiner
E A
EA
Al-Chalabi
A
A
Shaw
C E
CE
Brooks
D J
DJ
Leigh
P N
PN
Andersen
P M
PM
D000328:Adult; D000368:Aged; D000690:Amyotrophic Lateral Sclerosis / Q000000981:diagnostic imaging / Q000235:genetics* / Q000378:metabolism*; D002540:Cerebral Cortex / Q000000981:diagnostic imaging / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010879:Piperazines / Q000493:pharmacokinetics*; D011485:Protein Binding; D011725:Pyridines / Q000493:pharmacokinetics*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D044282:Receptor, Serotonin, 5-HT1A / Q000378:metabolism*; D013482:Superoxide Dismutase / Q000235:genetics*; D000072105:Superoxide Dismutase-1; D014018:Tissue Distribution
D010879:Piperazines; D011725:Pyridines; D019275:Radiopharmaceuticals; C000606290:SOD1 protein, human; D044282:Receptor, Serotonin, 5-HT1A; C090413:N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide; D013482:Superoxide Dismutase; D000072105:Superoxide Dismutase-1